HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Balint Farkas Selected Research

Osteoprotegerin

8/2008Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Balint Farkas Research Topics

Disease

4Arthritis (Polyarthritis)
01/2009 - 04/2008
2Pelvic Organ Prolapse
01/2023 - 05/2017
2Ovarian Hyperstimulation Syndrome
03/2020 - 09/2013
2Ovarian Neoplasms (Ovarian Cancer)
03/2020 - 11/2013
2Pre-Eclampsia (Preeclampsia)
01/2018 - 01/2013
1Prolapse
10/2020
1Ascites
03/2020
1Endometriosis
03/2020
1Urinary Incontinence
05/2017
1Neoplasms (Cancer)
11/2013
1Ovarian Epithelial Carcinoma
11/2013
1Ovarian Diseases (Ovarian Disease)
09/2013
1Ectopic Pregnancy
10/2009
1Spondylitis
01/2009
1Bone Resorption
08/2008

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
03/2020 - 08/2008
3Proteoglycans (Proteoglycan)IBA
01/2009 - 04/2008
2Interleukin-17 (Interleukin 17)IBA
08/2008 - 07/2008
1Programmed Cell Death 1 ReceptorIBA
01/2018
1Immune Checkpoint ProteinsIBA
01/2018
1PerforinIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
11/2013
1Carboplatin (JM8)FDA LinkGeneric
11/2013
1Paclitaxel (Taxol)FDA LinkGeneric
11/2013
114-3-3 Proteins (14-3-3 Protein)IBA
11/2013
1Oral ContraceptivesIBA
11/2013
1Galectins (Galectin)IBA
01/2013
1Methotrexate (Mexate)FDA LinkGeneric
10/2009
1AntibodiesIBA
01/2009
1OsteoprotegerinIBA
08/2008
1LigandsIBA
07/2008
1AutoantibodiesIBA
04/2008

Therapy/Procedure

4Therapeutics
03/2020 - 04/2008
3Pessaries
01/2023 - 05/2017
1Hysterectomy
05/2017
1Drug Therapy (Chemotherapy)
11/2013
1Aftercare (After-Treatment)
09/2013